Liquid Neurotoxin Formulation Stabilized with Tryptophan or Tyrosine

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20240050539A1
SERIAL NO

18476731

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to stable liquid neurotoxin formulations which are free of animal proteins, comprising a surfactant, an amino acid selected from tryptophan and tyrosine, a buffer comprising sodium, chloride and phosphate ions, which have a pH between 5.5 and 8, and which are stable for 2 months. These compositions are suitable for use in therapy and in particular for administration to a patient to achieve a desired therapeutic or aesthetic effect. The invention also relates to the use of an amino acid selected from tryptophan and tyrosine to protect a proteinaceous neurotoxin from degradation in a liquid composition which is free of animal derived proteins.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
IPSEN BIOPHARM LIMITEDSLOUGH BERKSHIRE SL1 3XE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
AGREN, Barbro Mattmar, SE 5 10
EDSTROM, Emilia Uppsala, SE 5 10
FRIIS, Anna Uppsala, SE 5 10
GURELL, Ann Stockholm, SE 5 10
JARSTAD, Anders Uppsala, SE 9 19
PICKETT, Andrew Uppsala, SE 10 31
STAHL, Ulf Uppsala, SE 22 166

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation